THERALASE TECHNOLOGIES INC (TLT.CA) Fundamental Analysis & Valuation
TSX-V:TLT • CA88337V1004
0.265 CAD
-0.01 (-1.85%)
Last: Mar 9, 2026, 07:00 PM
This TLT.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
We assign a fundamental rating of 3 out of 10 to TLT. TLT was compared to 14 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of TLT have multiple concerns. TLT is valied quite expensively at the moment, while it does show a decent growth rate.
1. TLT.CA Profitability Analysis
1.1 Basic Checks
- In the past year TLT has reported negative net income.
- In the past year TLT has reported a negative cash flow from operations.
- TLT had negative earnings in each of the past 5 years.
- TLT had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- TLT has a Return On Assets (-144.90%) which is in line with its industry peers.
- Looking at the Return On Equity, with a value of -398.40%, TLT is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -144.9% | ||
| ROE | -398.4% | ||
| ROIC | N/A |
ROA(3y)-132.13%
ROA(5y)-105.29%
ROE(3y)-205.01%
ROE(5y)-152.63%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- TLT has a Gross Margin of 55.35%. This is comparable to the rest of the industry: TLT outperforms 50.00% of its industry peers.
- TLT's Gross Margin has improved in the last couple of years.
- TLT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 55.35% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.53%
GM growth 5Y53.42%
2. TLT.CA Health Analysis
2.1 Basic Checks
- TLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
- TLT has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, TLT has more shares outstanding
- The debt/assets ratio for TLT has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -14.51, we must say that TLT is in the distress zone and has some risk of bankruptcy.
- TLT has a better Altman-Z score (-14.51) than 64.29% of its industry peers.
- TLT has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
- TLT's Debt to Equity ratio of 0.19 is fine compared to the rest of the industry. TLT outperforms 78.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -14.51 |
ROIC/WACCN/A
WACC9.14%
2.3 Liquidity
- TLT has a Current Ratio of 0.83. This is a bad value and indicates that TLT is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a decent Current ratio value of 0.83, TLT is doing good in the industry, outperforming 64.29% of the companies in the same industry.
- TLT has a Quick Ratio of 0.83. This is a bad value and indicates that TLT is not financially healthy enough and could expect problems in meeting its short term obligations.
- TLT has a better Quick ratio (0.57) than 64.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.57 |
3. TLT.CA Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 23.81% over the past year.
- The Revenue has been growing slightly by 1.45% in the past year.
- The Revenue has been growing slightly by 1.40% on average over the past years.
EPS 1Y (TTM)23.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)1.45%
Revenue growth 3Y9.8%
Revenue growth 5Y1.4%
Sales Q2Q%-19.6%
3.2 Future
- TLT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 47.54% yearly.
- The Revenue is expected to grow by 252.61% on average over the next years. This is a very strong growth
EPS Next Y39.41%
EPS Next 2Y-10.08%
EPS Next 3Y47.54%
EPS Next 5YN/A
Revenue Next Year13.84%
Revenue Next 2Y27.09%
Revenue Next 3Y252.61%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. TLT.CA Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for TLT. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TLT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as TLT's earnings are expected to grow with 47.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.08%
EPS Next 3Y47.54%
5. TLT.CA Dividend Analysis
5.1 Amount
- No dividends for TLT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TLT.CA Fundamentals: All Metrics, Ratios and Statistics
TSX-V:TLT (3/9/2026, 7:00:00 PM)
0.265
-0.01 (-1.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-10 2025-11-10/bmo
Earnings (Next)03-10 2026-03-10
Inst Owners0%
Inst Owner ChangeN/A
Ins Owners2.72%
Ins Owner ChangeN/A
Market Cap68.12M
Revenue(TTM)1.00M
Net Income(TTM)-4.35M
Analysts84.44
Price Target0.71 (167.92%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.27%
Min EPS beat(2)-29.45%
Max EPS beat(2)2.91%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)12.22%
Min Revenue beat(2)6.67%
Max Revenue beat(2)17.77%
Revenue beat(4)3
Avg Revenue beat(4)33.52%
Min Revenue beat(4)-55.73%
Max Revenue beat(4)165.37%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)20%
EPS NY rev (1m)0%
EPS NY rev (3m)50%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 68.05 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 62.34 | ||
| P/tB | 62.34 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.02
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -144.9% | ||
| ROE | -398.4% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 55.35% | ||
| FCFM | N/A |
ROA(3y)-132.13%
ROA(5y)-105.29%
ROE(3y)-205.01%
ROE(5y)-152.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.53%
GM growth 5Y53.42%
F-Score4
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 37.44% | ||
| Cap/Sales | 9.78% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.57 | ||
| Altman-Z | -14.51 |
F-Score4
WACC9.14%
ROIC/WACCN/A
Cap/Depr(3y)14.29%
Cap/Depr(5y)27.96%
Cap/Sales(3y)3.87%
Cap/Sales(5y)8.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y39.41%
EPS Next 2Y-10.08%
EPS Next 3Y47.54%
EPS Next 5YN/A
Revenue 1Y (TTM)1.45%
Revenue growth 3Y9.8%
Revenue growth 5Y1.4%
Sales Q2Q%-19.6%
Revenue Next Year13.84%
Revenue Next 2Y27.09%
Revenue Next 3Y252.61%
Revenue Next 5YN/A
EBIT growth 1Y-1.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.97%
OCF growth 3YN/A
OCF growth 5YN/A
THERALASE TECHNOLOGIES INC / TLT.CA FAQ
What is the ChartMill fundamental rating of THERALASE TECHNOLOGIES INC (TLT.CA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to TLT.CA.
What is the valuation status for TLT stock?
ChartMill assigns a valuation rating of 1 / 10 to THERALASE TECHNOLOGIES INC (TLT.CA). This can be considered as Overvalued.
What is the profitability of TLT stock?
THERALASE TECHNOLOGIES INC (TLT.CA) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for TLT stock?
The Earnings per Share (EPS) of THERALASE TECHNOLOGIES INC (TLT.CA) is expected to grow by 39.41% in the next year.